May 22, 2024
Severs Disease Treatment Market

Leveraging Technology is Driving the Global Severs Disease Treatment Market Trends

The global Severs disease treatment market is characterized by growing use of minimally invasive surgeries and advanced imaging techniques for accurate diagnosis and treatment of this pediatric foot condition. Severs disease, also known as calcaneal apophysitis is a common cause of heel pain in children aged between 7 to 10 years resulting from inflammation of the growth plate in the heel bone. Treatment options for Severs disease include rest, ice therapy, custom orthotics, night splints and heels wedges. Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are also used to relieve pain and inflammation. In rare severe cases, minimally invasive corticosteroid injections guided by ultrasound may be administered to reduce swelling.

The Global Severs Disease Treatment Market is estimated to be valued at US$ 1.34 Bn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031.

Advancements in diagnostic modalities such as ultrasound and MRI aids in early detection and timely intervention for Severs disease. Moreover, adoption of computer-assisted orthotic manufacturing systems allows for precision-molding of custom foot orthotics tailored for individual patient needs.

Key Takeaways

Key players operating in the Severs disease treatment market are AstraZeneca , Horizon Therapeutics plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Cipla Inc., LEO Pharma A/S, AbbVie Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Lupin, Dr. Reddy’s Laboratories Ltd., IBSA Institut Biochimique SA.

The Severs Disease Treatment Market Growth pediatric population and rising participation of children in sports activities is fueling demand for Severs disease treatment. According to estimates, over 20% of young athletes experience symptoms associated with this condition annually.

The market is witnessing expansion in emerging economies of Asia Pacific and Latin America driven by improving access to healthcare facilities and medical insurance coverage for pediatric foot conditions. Moreover, several market players are strengthening their distribution networks in developing nations to tap new growth opportunities.

Market Key Trends

One of the key trends shaping the Severs disease treatment market is the influx of digital health solutions. Pediatric podiatrists and physical therapists are leveraging virtual platforms to provide remote guidance on custom orthotic fittings, exercises and lifestyle management. This enables continuity of care while practice operations are optimized. Furthermore, AI and big data analytics are being explored to develop personalized treatment algorithms based on a child’s medical history, activities and foot structure. Such technological advancements aim to enhance outcomes through precision medicine approaches for Severs disease.

Porter’s Analysis

Threat of new entrants: New players need significant investment in R&D to develop novel treatment options for severs disease. Most severs disease treatments are patented by key players making entry difficult.

Bargaining power of buyers: Buyers have moderate bargaining power due to availability of treatment alternatives and generic options. However specialty branded treatments have pricing power.

Bargaining power of suppliers: Suppliers of active pharmaceutical ingredients have moderate bargaining power due to availability of alternative suppliers and ingredients.

Threat of new substitutes: Threat of new substitutes is moderate as severs disease has limited treatment options currently. New substitute delivery mechanisms can pose threat.

Competitive rivalry: Intense competition among key players to gain higher market share.

Geographical Regions

North America region accounted for the largest share of the severs disease treatment market in 2024, mainly due to higher prevalence of severs disease, strong healthcare infrastructure, and presence of key market players. The Asia Pacific region is poised to be the fastest growing market during the forecast period driven by increasing healthcare expenditure, large patient pool, and growth of medical tourism in the region.

Around 45% of the global severs disease treatment market value was concentrated in the North America region in 2024 led by the US market. The Asia Pacific region is expected to witness the fastest CAGR of 6.2% during the forecast period 2024-2031. Factors such as rising awareness, improving healthcare infrastructure, and increasing penetration of health insurance are driving the growth of severs disease treatment market in Asia Pacific countries like India and China.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it